Roderick H Dashwood
Overview
Explore the profile of Roderick H Dashwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
4286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tripathi C, Tovar Perez J, Kapoor S, Muhsin A, Dashwood W, Demirhan Y, et al.
Int J Cancer
. 2025 Mar;
PMID: 40072251
A previously reported clinical trial in familial adenomatous polyposis (FAP) patients treated with erlotinib plus sulindac (ERL + SUL) highlighted immune response/interferon-γ signaling as a key pathway. In this study,...
2.
Mohan N, Johnson G, Tovar Perez J, Dashwood W, Rajendran P, Dashwood R
Cell Death Dis
. 2024 Aug;
15(8):570.
PMID: 39112459
Bromodomain Adjacent to Zinc Finger Domain 1A (BAZ1A) is a critical regulator of chromatin remodeling. We sought to clarify the roles of BAZ1A in the etiology of colorectal cancer, including...
3.
Tovar Perez J, Zhang S, Hodgeman W, Kapoor S, Rajendran P, Kobayashi K, et al.
Clin Epigenetics
. 2024 Jun;
16(1):83.
PMID: 38915093
Background: Gastrointestinal malignancies encompass a diverse group of cancers that pose significant challenges to global health. The major histocompatibility complex (MHC) plays a pivotal role in immune surveillance, orchestrating the...
4.
Liu M, Zhong X, Krishnachaitanya S, Ou R, Dashwood R, Powell D, et al.
Biomed Pharmacother
. 2024 May;
175:116580.
PMID: 38723513
Colitis-associated cancer (CAC) in inflammatory bowel diseases exhibits more aggressive behavior than sporadic colorectal cancer; however, the molecular mechanisms remain unclear. No definitive preventative agent against CAC is currently established...
5.
Mohan N, Dashwood R, Rajendran P
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539439
Epigenetic 'reader' proteins, which have evolved to interact with specific chromatin modifications, play pivotal roles in gene regulation. There is growing interest in the alternative splicing mechanisms that affect the...
6.
Neja S, Dashwood W, Dashwood R, Rajendran P
Nutrients
. 2024 Feb;
16(3).
PMID: 38337680
Cancer etiology involves complex interactions between genetic and non-genetic factors, with epigenetic mechanisms serving as key regulators at multiple stages of pathogenesis. Poor dietary habits contribute to cancer predisposition by...
7.
Xiao Y, Lian H, Zhong X, Krishnachaitanya S, Cong Y, Dashwood R, et al.
Front Immunol
. 2022 Oct;
13:1020902.
PMID: 36275703
Background: Previous studies implicated matrix metalloproteinases (MMPs), such as MMP-7, in inflammatory bowel diseases (IBD) by showing increased activity during inflammation of the gut. However, the pathophysiological roles of MMP-7...
8.
Mohammed A, Dashwood R, Dickinson S, Disis M, Jaffee E, Johnson B, et al.
J Cancer Prev
. 2022 Jan;
26(4):309-317.
PMID: 35047458
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the "Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents" as a virtual 2-day workshop on...
9.
Chen Y, Li J, Menon R, Jayaraman A, Lee K, Huang Y, et al.
Gut Microbes
. 2021 Sep;
13(1):1972756.
PMID: 34494932
Complex interrelationships govern the dynamic interactions between gut microbes, the host, and exogenous drivers of disease outcome. A multi-omics approach to cancer prevention by spinach (SPI) was pursued for the...
10.
Miller M, Allen P, Brown P, Chan A, Clapper M, Dashwood R, et al.
J Cancer Prev
. 2021 Apr;
26(1):71-82.
PMID: 33842408
The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention...